[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 399 9500", "website": "https://www.tscan.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 that is in Phase I clinical trial for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. It also develops TSC-200, TSC-201, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors; and TSC-202 to treat solid tumors. In addition, the company develops vaccines for infectious diseases, such as SARS-CoV-2. It has collaborations with Novartis Institutes for BioMedical Research, Inc. To discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 188, "companyOfficers": [{"maxAge": 1, "name": "Dr. Gavin  MacBeath Ph.D.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 853513, "exercisedValue": 0, "unexercisedValue": 471064}, {"maxAge": 1, "name": "Dr. Zoran  Zdraveski J.D., Ph.D.", "age": 54, "title": "Chief Legal & Strategy Officer and Company Secretary", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 657200, "exercisedValue": 0, "unexercisedValue": 85247}, {"maxAge": 1, "name": "Dr. Stephen J. Elledge Ph.D.", "title": "Co-Founder & Chairman of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tomasz  Kula Ph.D.", "title": "Co-Founder & Member of Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason A. Amello CPA", "age": 56, "title": "CFO & Treasurer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Justin  McCue Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ann  Hargraves", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shrikanta  Chattopadhyay M.D.", "title": "Senior VP & Head of Translational Medicine", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ray  Lockard M.B.A.", "title": "Senior Vice President & Head of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jim  Murray", "title": "Senior VP & Head of Development Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.02, "open": 2.06, "dayLow": 1.97, "dayHigh": 2.155, "regularMarketPreviousClose": 2.02, "regularMarketOpen": 2.06, "regularMarketDayLow": 1.97, "regularMarketDayHigh": 2.155, "payoutRatio": 0.0, "beta": 0.869, "forwardPE": -1.6279069, "volume": 344649, "regularMarketVolume": 344649, "averageVolume": 477742, "averageVolume10days": 589510, "averageDailyVolume10Day": 589510, "bid": 2.07, "ask": 2.14, "bidSize": 1, "askSize": 1, "marketCap": 118661336, "fiftyTwoWeekLow": 1.9, "fiftyTwoWeekHigh": 9.69, "priceToSalesTrailing12Months": 12.674785, "fiftyDayAverage": 2.5554, "twoHundredDayAverage": 5.2205, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -68685752, "profitMargins": 0.0, "floatShares": 34996166, "sharesOutstanding": 52228800, "sharesShort": 2002749, "sharesShortPriorMonth": 1998350, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0354, "heldPercentInsiders": 0.00823, "heldPercentInstitutions": 0.90725, "shortRatio": 8.88, "shortPercentOfFloat": 0.0479, "impliedSharesOutstanding": 5143130, "bookValue": 4.294, "priceToBook": 0.48905444, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -111303000, "trailingEps": -0.95, "forwardEps": -1.29, "enterpriseToRevenue": -7.337, "enterpriseToEbitda": 0.598, "52WeekChange": -0.71629214, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 2.1, "targetHighPrice": 15.0, "targetLowPrice": 7.0, "targetMeanPrice": 12.14286, "targetMedianPrice": 12.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 271120000, "totalCashPerShare": 5.08, "ebitda": -114789000, "totalDebt": 90356000, "quickRatio": 9.46, "currentRatio": 9.563, "totalRevenue": 9362000, "debtToEquity": 39.442, "revenuePerShare": 0.175, "returnOnAssets": -0.23355, "returnOnEquity": -0.55924, "grossProfits": -91040000, "freeCashflow": -71110872, "operatingCashflow": -107176000, "revenueGrowth": -0.73, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -31.09819, "financialCurrency": "USD", "symbol": "TCRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NGM", "messageBoardId": "finmb_583057578", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "longName": "TScan Therapeutics, Inc.", "shortName": "TScan Therapeutics, Inc.", "regularMarketChangePercent": 3.9603922, "regularMarketPrice": 2.1, "corporateActions": [], "postMarketTime": 1740790611, "regularMarketTime": 1740776400, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626442200000, "postMarketChangePercent": -4.28571, "postMarketPrice": 2.01, "postMarketChange": -0.0899999, "regularMarketChange": 0.07999992, "regularMarketDayRange": "1.97 - 2.155", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 477742, "fiftyTwoWeekLowChange": 0.19999993, "fiftyTwoWeekLowChangePercent": 0.10526312, "fiftyTwoWeekRange": "1.9 - 9.69", "fiftyTwoWeekHighChange": -7.5899997, "fiftyTwoWeekHighChangePercent": -0.78328174, "fiftyTwoWeekChangePercent": -71.62921, "epsTrailingTwelveMonths": -0.95, "epsForward": -1.29, "epsCurrentYear": -1.1216, "priceEpsCurrentYear": -1.8723251, "fiftyDayAverageChange": -0.4554, "fiftyDayAverageChangePercent": -0.17821085, "twoHundredDayAverageChange": -3.1205, "twoHundredDayAverageChangePercent": -0.5977397, "displayName": "TScan Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]